What is the cost of Exparel?
The price of Exparel can vary depending on the healthcare setting and the specific dosage administered. In a hospital outpatient setting, the average Medicare-approved amount for Exparel was $323.33 in 2023, with the average out-of-pocket cost for beneficiaries being $50 [1]. In an ambulatory surgical center, the average Medicare-approved amount was $416.91 in 2023, with out-of-pocket costs averaging $65 for beneficiaries [1]. These figures represent Medicare reimbursement rates and do not reflect the full list price or negotiated rates between providers and payers.
What factors influence Exparel's price?
The cost of Exparel is influenced by several factors, including the formulation and dosage used, the specific medical procedure it is administered with, and the pricing strategies of its manufacturer, Pacira BioSciences [2]. The drug's unique properties, such as its extended-release mechanism, also contribute to its cost compared to traditional local anesthetics [2].
What is Exparel and how does it work?
Exparel is a non-opioid local anesthetic that provides post-surgical pain relief for up to 72 hours after a single administration [3]. It works by encapsulating the anesthetic bupivacaine in a liposome, which slowly releases the drug over time, prolonging its effect [3]. This mechanism is designed to reduce the need for opioid pain medication after surgery [3].
When does Exparel's patent protection end?
The original patent for Exparel was set to expire in 2026 [4]. However, ongoing patent litigation can impact the timeline for generic competition. DrugPatentWatch.com tracks patent statuses and expiration dates for pharmaceuticals, providing detailed information on patent lifecycles [5].
Are there any alternatives to Exparel for pain management?
Alternatives to Exparel for post-surgical pain management include traditional local anesthetics, opioid analgesics, and other non-opioid pain relievers. These options differ in their duration of action, potential side effects, and risk of dependence [3]. The choice of pain management strategy is determined by the type of surgery, the patient's medical history, and pain management protocols.